Table 7.

Comparison of survival between males and females stratified by treatment modality

	1 year (%)	3 years (%)	5 years (%)	P value
Curative ‡
Male	87	67	50	0.310
Female	92	73	57
Non‐curative †
Male	39	13	5	0.178
Female	43	19	16
Best supportive care
Male	13	1	0	0.114
Female	17	3	0

^† Non‐curative: TACE, Y90‐SIRT, SBRT, or systemic therapy.

^‡ Curative: Resection, radiofrequency ablation, or liver transplant.